Genetic screening for two LRRK2 mutations in French patients with idiopathic Parkinson's disease

Genetic Testing

Volumn 10, Issue 4, 2006, Pages 290-293

  Funalot, Benoît ^a   Nichols, William C ^b   Pérez Tur, Jordi ^c   Mercier, Géraldine ^d   Lucotte, Gérard ^d,e  

^a CENTRE PAUL BROCA   (France)

^b CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^c INSTITUTO DE BIOMEDICINA DE VALENCIA   (Spain)

^d Centre de Neurogenetique Moleculaire   (France)

^e Center of Molecular Neurogenetics   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; AMINO ACID SUBSTITUTION; ARTICLE; CLINICAL FEATURE; ETHNIC DIFFERENCE; FEMALE; FRANCE; GENE; GENE EXPRESSION PROFILING; GENE MUTATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC SCREENING; HAPLOTYPE; HETEROZYGOTE; HUMAN; LRRK2 GENE; MAJOR CLINICAL STUDY; MALE; MUTATIONAL ANALYSIS; NORTH AFRICA; PARKINSON DISEASE;

ADULT; AGED; AGED, 80 AND OVER; DNA MUTATIONAL ANALYSIS; FEMALE; FRANCE; GENETIC SCREENING; HUMANS; MALE; MICROSATELLITE REPEATS; MIDDLE AGED; MUTATION; PARKINSON DISEASE; PROTEIN-SERINE-THREONINE KINASES;

EID: 33846708521     PISSN: 10906576     EISSN: None     Source Type: Journal    
DOI: 10.1089/gte.2006.10.290     Document Type: Article

References (18)

1. Aasly JO, Toft M, Fernandez-Mata I, Kachergus J, Hulihan M, White LR, Farrer MJ (2005) Clinical features of LRRK2-associated Parkinson's disease in Central Norway. Ann Neurol 57:762-765.
2. Bras JM, Guerreiro RJ, Ribeiro MH, Januairio C, Morgadinho A, Oliveira CR, Cunha L, Hardy J, Singleton A (2005) G2019S dardarin substitution is a common cause of Parkinson's disease in a Portuguese cohort. Mov Disord 20:1653-1655.
3. Deng H, Le W, Guo Y, Hunter CB, Xie W, Jankovic J (2005) Genetic and clinical identification of Parkinson's disease patients with LRRK2 G2019S mutation. Ann Neurol 6:933-934.
4. Di Fonzo A, Rohe CF, Ferreira J, Chien HF, Vacca L, Stocchi F, Guedes L, Fabrizio E, Manfredi M, Vanacore N, Goldwurm S, Breedveld G, Sampaio C, Meco G, Barbosa E, Oostra BA, Bonifati V (2005) A frequent LRRK2 gene mutation associated with autosomal dominant Parkinson's disease. Lancet 365:412-415.
5. Funayama M, Hasegawa K, Kowa H, Saito M, Tsuji S, Obata F (2002) A new locus for Parkinson's disease (PARK8) maps to chromosome 12p11.2-q13.1. Ann Neurol 51:296-301.
6. Gérard N, Panserat S, Lucotte G (2002) Roles of gender, age at onset and environmental risk in the frequency of CYP2D6-deficient alleles in patients with Parkinson's disease. Eur Neurol 48:114-115.
7. Gilks WP, Abou-Sleiman PM, Gandhi S, Jain S, Singleton A, Lees AJ, Shaw K, Bhatia KP, Bonifati V, Quinn NP, Lynch J, Healy DG, Holton JL, Revesz T, Wood NW (2005) A common LRRK2 mutation in idiopathic Parkinson's disease. The Lancet 365:415-416.
8. Hardy J (2003) Impact of genetic analysis on Parkinson's disease research. Mov Disord 18 (Suppl 6):S96-S98.
9. Hernandez DG, Paisán-Ruiz C, Mcinerney-Leo A, Jain S, Meyer-Lindenberg A, Evans EW, Berman KF, Johnson J, Auburger G, Schäffer AA, Lopez GJ, Nussbaum RL, Singleton AB (2005) Clinical and positron emission tomography of Parkinson's disease caused by LRRK2. Ann Neurol 57:453-456.
10. Kachergus J, Mata IF, Hulihan M, Taylor JP, Lincoln S, Aasly J, Gibson JM, Ross OA, Lynch T, Wiley J, Payami H, Nutt J, Maraganore DM, Czyzewski K, Styczynska M, Wszolek K, Farrer MJ, Toft M (2005) Identification of a novel LRRK2 mutation liked to autosomal dominant parkinsonism: evidence for a common founder across European populations. Am J Hum Genet 76:672-680.
11. Lesage S, Ibanez P, Lohmann E, Pollak P, Tison F, Tazir M, Leutenegger AL, Guimaraes J, Bonnet AM, Agid Y, Durr A, Brice A (2005a) G2019S LRRK2 mutation in French and North African families with Parkinson's disease. Ann Neurol 58:784-787.
12. th century. Am J hum Genet 77:330-332.
13. Mata IF, Taylor JP, Kachergus J, Hulihan M, Huerta C, Lahoz C, Blazquez M, Guisasola LM, Salvador C, Ribacoba R, Martinez C, Farrer MJ, Alvarez V (2005) LRRK2 R14441G in Spanish patients with Parkinson's disease. Neurosci Lett 382:309-311.
14. Nichols WC, Pankratz N, Hernandez D, Paisán-Ruiz C, Jain S, Halter CA, Michaels VE, Reed T, Rudolph A, Shults CW, Singleton A, Foroud T (2005) Genetic screening for a single common LRRK2 mutation in familial Parkinson's disease. Lancet 365:410-412.
15. Paisán-Ruiz C, Jain S, Evans EW, Gilks, WP, Simón J, Van Der Brug M, López de Munain A, Aparicio S, Martínez Gil A, Khan N, Johnson J, Ruiz Martinez J, Nicholl D, Marti Carrera I, Saenz Peña A, de Silva R, Lees A, Martí-Massó JF, Pérez-Tur J, Wood NW, Singleton AB (2004) Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease. Neuron 44:595-600.
16. Santt O, Baranova H, Albuisson E, Bignon YJ, Lucotte G (2004) Interaction between GSTM1-null and CYP2D6-deficient alleles in the pathogenesis of Parkinson's disease. Eur J Neurol 11:247-251.
17. Zabetian CP, Samii A, Mosley AD, Roberts JW, Leis BC, Yearout D, Raskind WH, Griffith A (2005) A clinic-based study of the LRRK2 gene in Parkinson's disease yields new mutations. Mov Disord 20:s1235.
18. Zimprich A, Biskup S, Leitner P, Lichtner P, Farrer M, Lincoln S, Kachergus J, Hulihan M, Uitti RJ, Calne DB, Stoessi J, Pfeiffer RF, Patenge N, Carbajal IC, Vieregge P, Asmus F, Müller-Myhsok B, Dickson DW, Meitinger T, Strom TM, Wszolek ZK, Gasser T (2004) Mutations in LRRK2 cause autosomal-dominant Parkinsonism with pleomorphic pathology. Neuron 44:601-607.